38 related articles for article (PubMed ID: 28641336)
21. Xenograft models for adrenocortical carcinoma.
Hantel C; Beuschlein F
Mol Cell Endocrinol; 2016 Feb; 421():28-33. PubMed ID: 26033247
[TBL] [Abstract][Full Text] [Related]
22. MECHANISMS OF ENDOCRINOLOGY: Cell cycle regulation in adrenocortical carcinoma.
Pereira SS; Monteiro MP; Bourdeau I; Lacroix A; Pignatelli D
Eur J Endocrinol; 2018 Aug; 179(2):R95-R110. PubMed ID: 29773584
[TBL] [Abstract][Full Text] [Related]
23. Forkhead Box Protein O1: Functional Diversity and Post-Translational Modification, a New Therapeutic Target?
Zhang X; Jiang L; Liu H
Drug Des Devel Ther; 2021; 15():1851-1860. PubMed ID: 33976536
[TBL] [Abstract][Full Text] [Related]
24. Deciphering the roles of FOXO1 in human neoplasms.
Jiang S; Li T; Yang Z; Hu W; Yang Y
Int J Cancer; 2018 Oct; 143(7):1560-1568. PubMed ID: 29473160
[TBL] [Abstract][Full Text] [Related]
25. The role of epithelial growth factors and insulin growth factors in the adrenal neoplasms.
Angelousi A; Kyriakopoulos G; Nasiri-Ansari N; Karageorgou M; Kassi E
Ann Transl Med; 2018 Jun; 6(12):253. PubMed ID: 30069455
[TBL] [Abstract][Full Text] [Related]
26. Metabolic aspects of cardiovascular diseases: Is FoxO1 a player or a target?
Menghini R; Casagrande V; Iuliani G; Rizza S; Mavilio M; Cardellini M; Federici M
Int J Biochem Cell Biol; 2020 Jan; 118():105659. PubMed ID: 31765819
[TBL] [Abstract][Full Text] [Related]
27. A global perspective on FOXO1 in lipid metabolism and lipid-related diseases.
Li Y; Ma Z; Jiang S; Hu W; Li T; Di S; Wang D; Yang Y
Prog Lipid Res; 2017 Apr; 66():42-49. PubMed ID: 28392404
[TBL] [Abstract][Full Text] [Related]
28. FOXO1/3: Potential suppressors of fibrosis.
Xin Z; Ma Z; Hu W; Jiang S; Yang Z; Li T; Chen F; Jia G; Yang Y
Ageing Res Rev; 2018 Jan; 41():42-52. PubMed ID: 29138094
[TBL] [Abstract][Full Text] [Related]
29. Suppression of Forkhead Box Protein O1 (FOXO1) Transcription Factor May Promote Adrenocortical Tumorigenesis.
Stenman A; Murtha T; Korah R; Carling T
Horm Metab Res; 2017 Aug; 49(8):631-637. PubMed ID: 28641336
[TBL] [Abstract][Full Text] [Related]
30. Adrenocortical carcinoma: review of the pathologic features, production of adrenal steroids, and molecular pathogenesis.
Nakamura Y; Yamazaki Y; Felizola SJ; Ise K; Morimoto R; Satoh F; Arai Y; Sasano H
Endocrinol Metab Clin North Am; 2015 Jun; 44(2):399-410. PubMed ID: 26038208
[TBL] [Abstract][Full Text] [Related]
31. Molecular markers and the pathogenesis of adrenocortical cancer.
Soon PS; McDonald KL; Robinson BG; Sidhu SB
Oncologist; 2008 May; 13(5):548-61. PubMed ID: 18515740
[TBL] [Abstract][Full Text] [Related]
32. Multifaceted functions of the forkhead box transcription factors FoxO1 and FoxO3 in skin.
Tsitsipatis D; Klotz LO; Steinbrenner H
Biochim Biophys Acta Gen Subj; 2017 May; 1861(5 Pt A):1057-1064. PubMed ID: 28249743
[TBL] [Abstract][Full Text] [Related]
33. Adrenocortical stem and progenitor cells: implications for adrenocortical carcinoma.
Simon DP; Hammer GD
Mol Cell Endocrinol; 2012 Mar; 351(1):2-11. PubMed ID: 22266195
[TBL] [Abstract][Full Text] [Related]
34. The molecular basis of adrenocortical cancer.
Lehmann T; Wrzesinski T
Cancer Genet; 2012 Apr; 205(4):131-7. PubMed ID: 22559973
[TBL] [Abstract][Full Text] [Related]
35.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [New Search]
